Gilead Sciences (GILD) Net Income (2009 - 2026)
Gilead Sciences' Net Income was $2.43 billion in Q3 2026, down 20.4% from $3.05 billion a year earlier.
Gilead Sciences (GILD) Net Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gilead Sciences' Net Income was -$3.86 billion through Sep 30, 2026; for FY2025, it came in at $8.51 billion.
- Net Income shows a five-year compound annual growth rate of 133.3% (FY2020 to FY2025).
- In earlier years, Net Income was $480 million in FY2024 (-91.5%), $5.67 billion in FY2023 (+23.4%), $4.59 billion in FY2022 (-26.2%) and $6.23 billion in FY2021.
- Quarterly Net Income has moved between -$10.5 billion (Q2 2026) and $3.05 billion (Q3 2025) over five years.
- Compared with a year earlier, Net Income was higher in five of the last six quarters, with growth averaging 40.9%.
- The best year-over-year quarter for Net Income over five years was Q4 2022 (growth of 329.3%); the worst was Q1 2022 (a decline of 98.9%).
- Per Business Quant data, GILD's Net Income in the three quarters before Q3 2026 was -$10.5 billion (Q2 2026), $2.02 billion (Q1 2026) and $2.18 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.95 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 6.45 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 210.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 4.22 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.07 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 3.25 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.43 Bn |
| Jun 30, 2026 | -10.50 Bn |
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | -4.17 Bn |
| Dec 31, 2023 | 1.43 Bn |
| Sep 30, 2023 | 2.18 Bn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.64 Bn |
| Sep 30, 2022 | 1.79 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 382.00 Mn |
Gilead Sciences Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();